Inherited Disorders of Hemostasis in Dogs and Cats

Topics in Companion Animal Medicine

Volumn 27, Issue 2, 2012, Pages 53-58

  Barr, James W ^a   McMichael, Maureen ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Coagulation; Hemophilia; Hemostasis; Von Willebrand disease

Indexed keywords

BLOOD CLOTTING FACTOR;

ANIMAL; ANIMAL DISEASE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BREEDING; CAT; CAT DISEASE; DOG; DOG DISEASE; GENETIC SCREENING; GENETICS; PHYSIOLOGY; REVIEW; THROMBOCYTE;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS, INHERITED; BLOOD COAGULATION FACTORS; BLOOD PLATELETS; BREEDING; CAT DISEASES; CATS; DOG DISEASES; DOGS; GENETIC TESTING;

ANIMALIA; CANIS FAMILIARIS;

EID: 84867000894     PISSN: 19389736     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.tcam.2012.07.006     Document Type: Review

References (53)

1. Ingram G.I. The history of haemophilia. J Clin Pathol 1976, 29(6):469-479.
2. Kaadan A.N., Angrini M. Who discovered hemophilia. J Int Soc Hist Islamic Med 2010, 8-9(15):46-50.
3. Massie R.K. Nicholas and Alexandra 1985, Dell, New York, NY.
4. Carr A.P., Nibblett B.M., Panciera D.L. von Willebrand's disease and other hereditary coagulopathies. Kirk's Current Veterinary Therapy; XIV 2009, 277-280. Saunders Elsevier, St. Louis, MO. 14th ed. J. Bonagura, D. Twedt (Eds.).
5. Brooks M. A review of canine inherited bleeding disorders: biochemical and molecular strategies for disease characterization and carrier detection. J Hered 1999, 90(1):112-118.
6. Boudreaux M.K., Catalfamo J.L., Klok M. Calcium-diacylglycerol guanine nucleotide exchange factor I gene mutations associated with loss of function in canine platelets. Transl Res 2007, 150(2):81-92.
7. Brooks M.B. Hereditary coagulopathies. Schalm's Veterinary Hematology 2010, 661-667. Wiley, Ames, IA. 6th ed. D.J. Weiss, K.J. Wardrop (Eds.).
8. Pipe S.W., High K.A., Ohashi K., Ural A.U., Lillicrap D. Progress in the molecular biology of inherited bleeding disorders. Haemophilia 2008, 14(suppl 3):130-137.
9. Boudreaux M.K. Inherited platelet disorders. J Vet Emerg Crit Care 2012, 22(1):30-41.
10. Brooks M.B., Catalfamo J.L. Von Willebrand disease. Schalm's Veterinary Hematology 2010, 612-618. Wiley, Ames, IA. 6th ed. D.J. Weiss, K.J. Wardrop (Eds.).
11. Nachman R.L., Rafii S. Platelets, petechiae, and preservation of the vascular wall. N Engl J Med 2008, 359(12):1261-1270.
12. Wagner D.D. Cell biology of von Willebrand factor. Annu Rev Cell Biol 1990, 6:217-246.
13. Rodeghiero F., Castaman G., Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987, 69(2):454-459.
14. Johnson G.S., Turrentine M.A., Kraus K.H. Canine von Willebrand's disease. A heterogeneous group of bleeding disorders. Vet Clin North Am Small Anim Pract 1988, 18(1):195-229.
15. Brooks M. Management of canine von Willebrand's disease. Probl Vet Med 1992, 4(4):636-646.
16. Dodds W.J. Von Willebrand's disease in dogs. Mod Vet Pract 1984, 65(9):681-686.
17. Thomas J.S. von Willebrand's disease in the dog and cat. Vet Clin North Am Small Anim Pract 1996, 26(5):1089-1110.
18. Johnstone I.B., Crane S. Von Willebrand's disease in two families of Doberman Pinschers. Can Vet J 1981, 22(8):239-243.
19. Littlewood J.D., Herrtage M.E., Gorman N.T., McGlennon N.J. Von Willebrand's disease in dogs in the United Kingdom. Vet Rec 1987, 121(20):463-468.
20. Meyers K.M., Wardrop K.J., Dodds W.J., Brassard J. Effect of exercise, DDAVP, and epinephrine on the factor VIII:C/von Willebrand factor complex in normal dogs and von Willebrand factor deficient Doberman pinscher dogs. Thromb Res 1990, 57(1):97-108.
21. Nurden A.T., George J.N. Inherited abnormalities of the platelet membrane: Glanzmann thrombasthenia, Bernard-Soulier syndrome, and other disorders. Hemostasis and Thrombosis 2006, 987-1010. Lippincott Williams & Wilkins, Philadelphia, PA. 5th ed. R.W. Coleman, V.J. Marder, A.W. Clowes, J.N. George, S.Z. Goldhaber (Eds.).
22. Boudreaux M.K., Kvam K., Dillon A.R., et al. Type I Glanzmann's thrombasthenia in a Great Pyrenees dog. Vet Pathol 1996, 33(5):503-511.
23. Lipscomb D.L., Bourne C., Boudreaux M.K. Two genetic defects in alphaIIb are associated with type I Glanzmann's thrombasthenia in a Great Pyrenees dog: a 14-base insertion in exon 13 and a splicing defect of intron 13. Vet Pathol 2000, 37(6):581-588.
24. Boudreaux M.K., Catalfamo J.L. Molecular and genetic basis for thrombasthenic thrombopathia in otterhounds. Am J Vet Res 2001, 62(11):1797-1804.
25. Fang J., Jensen E.S., Boudreaux M.K., et al. Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogs. Proc Natl Acad Sci U S A 2011, 108(23):9583-9588.
26. Boudreaux M.K., Martin M. P2Y12 receptor gene mutation associated with postoperative hemorrhage in a Greater Swiss Mountain dog. Vet Clin Pathol 2011, 40(2):202-206. 2011.
27. Boudreaux M.K., Catalfamo J.L. Platelet biochemistry, signal transduction, and function. Schalm's Veterinary Hematology 2010, 569-575. Wiley, Ames, IA. 6th ed. D.J. Weiss, K.J. Wardrop (Eds.).
28. Savi P., Zachayus J.L., Delesque-Touchard N., et al. The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts. Proc Natl Acad Sci U S A 2006, 103(29):11069-11074.
29. Reese E.S., Daniel Mullins C., Beitelshees A.L., Onukwugha E. Cost-effectiveness of cytochrome P450 2C19 genotype screening for selection of antiplatelet therapy with clopidogrel or prasugrel. Pharmacotherapy 2012, 32(4):323-332.
30. Kasirer-Friede A., Qin J., Plow E.F., Shattil S.J. Integrin alphaIIb-beta3 and Platelet Aggregation. Hemostasis and Thrombosis 2006, 517-529. Lippincott Williams & Wilkins, Philadelphia, PA. 5th ed. R.W. Coleman, V.J. Marder, A.W. Clowes, J.N. George, S.Z. Goldhaber (Eds.).
31. Moser M., Nieswandt B., Ussar S., Pozgajova M., Fässler R. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med 2008, 14(3):325-330.
32. Huizing M., Anikster Y., Gahl W.A. Hermansky-Pudlak syndrome and Chediak-Higashi syndrome: disorders of vesicle formation and trafficking. Thromb Haemost 2001, 86(1):233-245.
33. Boudreaux M.K. Inherited intrinsic platelet disorders. Schalm's Veterinary Hematology 2010, 619-625. Wiley, Ames, IA. 6th ed. D.J. Weiss, K.J. Wardrop (Eds.).
34. DiGiacomo R.F., Hammond W.P., Kunz L.L., Cox P.A. Clinical and pathologic features of cyclic hematopoiesis in grey collie dogs. Am J Pathol 1983, 111(2):224-233.
35. Cheville N.F., Cutlip R.C., Moon H.W. Microscopic pathology of the gray collie syndrome. Cyclic neutropenia, amyloidosis, enteritis, and bone necrosis. Pathol Vet 1970, 7(3):225-245.
36. Callan M.B., Bennett J.S., Phillips D.K., et al. Inherited platelet delta-storage pool disease in dogs causing severe bleeding: an animal model for a specific ADP deficiency. Thromb Haemost 1995, 74(3):949-953.
37. Smith S.A. Overview of hemostasis. Schalm's Veterinary Hematology 2010, 635-653. Wiley, Ames, IA. 6th ed. D.J. Weiss, K.J. Wardrop (Eds.).
38. Morrissey J.H., Mutch N.J. Tissue factor structure and function. Hemostasis and Thrombosis 2006, 91-106. Lippincott Williams & Wilkins, Philadelphia, PA. 5th ed. R.W. Coleman, V.J. Marder, A.W. Clowes, J.N. George, S.Z. Goldhaber (Eds.).
39. Giangrande P.L. Six characters in search of an author: the history of the nomenclature of coagulation factors. Br J Haematol 2003, 121(5):703-712.
40. Roberts H.R., Escobar M.A. Inherited disorders of prothrombin conversion. Hemostasis and Thrombosis 2006, 923-937. Lippincott Williams & Wilkins, Philadelphia, PA. 5th ed. R.W. Coleman, V.J. Marder, A.W. Clowes, J.N. George, S.Z. Goldhaber (Eds.).
41. Jandrey K.E. Assessment of platelet function. J Vet Emerg Crit Care 2012, 22(1):81-98.
42. Lubas G., Caldin M., Wiinberg B., Kristensen A.T. Laboratory testing of coagulation disorders. Schalm's Veterinary Hematology 2010, 1082-1100. Wiley, Ames, IA. 6th ed. D.J. Weiss, K.J. Wardrop (Eds.).
43. Seligsohn U. Treatment of inherited platelet disorders. Haemophilia 2012, 18(suppl 4):161-165.
44. Alamelu J., Liesner R. Modern management of severe platelet function disorders. Br J Haematol 2010, 149(6):813-823.
45. Bolton-Maggs P.H., Chalmers E.A., Collins P.W., et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006, 135(5):603-633.
46. Marín L.M., Iazbik M.C., Zaldivar-Lopez S., et al. Retrospective evaluation of the effectiveness of epsilon aminocaproic acid for the prevention of postamputation bleeding in retired racing Greyhounds with appendicular bone tumors: 46 cases (2003-2008). J Vet Emerg Crit Care (San Antonio) 2012, 22(3):332-340.
47. Ching Y.N., Meyers K.M., Brassard J.A., Wardrop K.J. Effect of cryoprecipitate and plasma on plasma von Willebrand factor multimeters and bleeding time in Doberman Pinschers with type-I von Willebrand's disease. Am J Vet Res 1994, 55(1):102-110.
48. Callan M.B., Giger U. Effect of desmopressin acetate administration on primary hemostasis in Doberman Pinschers with type-1 von Willebrand disease as assessed by a point-of-care instrument. Am J Vet Res 2002, 63(12):1700-1706.
49. Callan M.B., Giger U., Catalfamo J.L. Effect of desmopressin on von Willebrand factor multimers in Doberman Pinschers with type 1 von Willebrand disease. Am J Vet Res 2005, 66(5):861-867.
50. Coppola A., Di Minno G. Desmopressin in inherited disorders of platelet function. Haemophilia 2008, 14(suppl 1):31-39.
51. Mannucci P., Cattaneo M. Desmopressin (DDAVP). Platelets 2007, 1237-1249. Elsevier, Amsterdam, The Netherlands. 2nd ed. A. Michelson (Ed.).
52. Kobrinsky N.L., Israels E.D., Gerrard J.M., et al. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders. Lancet 1984, 1(8387):1145-1148.
53. Cattaneo M. Desmopressin in the treatment of patients with defects of platelet function. Haematologica 2002, 87(11):1122-1124.